Type 2 Diabetes Mellitus Completed Phase 2 Trials for Pioglitazone (DB01132)

Also known as: Diabetes Mellitus Non-insulin-dependent / Type-2 Diabetes Mellitus / Diabetes Mellitus Type 2 (T2DM) / Diabetes Mellitus Type-2 / Type 2 Diabetes (T2DM) / Diabetes, Type 2 / Diabetes Mellitus, Type 2 (T2DM) / Diabetes Mellitus´╝îType 2 / Diabetes Type II / Type-II Diabetes Mellitus / Diabetes Mellitus 2 Type / T2DM / Diabetes Mellitus Type II / Type II Diabetes / Diabetes Mellitus, Type 2 / Type 2 Diabetes Mellitus (T2DM) / Diabetes Type Two / Diabetes Mellitus - Type 2 / Diabetes, Type II / Non-Insulin-Dependent Diabetes Mellitus / Diabetes Mellitus. Type 2 / Diabetes Type 2 / Type 2 Diabetes Mellitus (T2D) / Type 2 Diabetes (T2D) / Type II; Diabetes / Type II Diabetes Mellitus / Diabetes Mellitus, Type II / NIDDM / Type-2 Diabetes / Type 2 Diabetes Mellitus(T2DM) / Type 2 Diabetes / Type 2-diabetes / Noninsulin Dependent Diabetes Mellitus, Type II / Diabetes Mellitus Type 2 / Type Two Diabetes Mellitus / T2DM (Type 2 Diabetes Mellitus) / Type-2-diabetes Mellitus / Diabetes mellitus -adult onset / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00280865GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesTreatment
NCT00443755Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin ResistanceTreatment
NCT00575874Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 DiabetesTreatment
NCT00771004Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.Treatment
NCT01103414Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic PatientsTreatment
NCT01217073A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)Treatment
NCT00631007A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active ComparatorTreatment
NCT00760578A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active ComparatorTreatment
NCT01028963A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes MellitusTreatment
NCT00461006A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.Treatment
NCT00388518A Study of Aleglitazar in Patients With Type 2 DiabetesTreatment
NCT00461058A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.Treatment
NCT01043029A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal ImpairmentTreatment
NCT00500331Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)Treatment
NCT00196989Study In People With Type 2 DiabetesTreatment
NCT01230749A Study of Multiple Oral Doses of JNJ-41443532 in Patients With Type 2 Diabetes MellitusTreatment
NCT01935804Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 DiabetesTreatment
NCT00290940Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917Treatment
NCT01280695A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic PatientsTreatment